Zhican Wang
Impact in
-
- Vitamin D Research Studies
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Vitamin D Research Studies 13
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- Kenneth E. Thummel (16 shared papers)Erin G. Schuetz (4 shared papers)Yvonne S. Lin (6 shared papers)Yang Xu (1 shared paper)Connie L. Davis (3 shared papers)Danny D. Shen (3 shared papers)Jonathan Himmelfarb (3 shared papers)Xi Zheng (3 shared papers)
- Journals
- Drug Metabolism and Disposition (3 papers)Journal of Medicinal Chemistry (3 papers)Cancer Discovery (2 papers)Science (2 papers)Analytical and Bioanalytical Chemistry (1 paper)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Zhican Wang
31 papers receiving 1.6k citations
Zhican Wang's Hit Papers
Peers
Comparison fields: 5 of 104
- Pathology and Forensic Medicine 566
- Pharmacology 100
- Nutrition and Dietetics 168
- Nephrology 73
- Oncology 243
Countries citing papers authored by Zhican Wang
This map shows the geographic impact of Zhican Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhican Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhican Wang more than expected).
Fields of papers citing papers by Zhican Wang
This network shows the impact of papers produced by Zhican Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhican Wang. The network helps show where Zhican Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhican Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 215 | |
| 2 | Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers Hit paper breakdown → | 2024 | 195 |
| 3 | Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS Hit paper breakdown → | 2023 | 177 |
| 4 | 2012 | 103 | |
| 5 | 2011 | 96 | |
| 6 | 2011 | 82 | |
| 7 | 2012 | 68 | |
| 8 | 2012 | 66 | |
| 9 | 2014 | 65 | |
| 10 | 2020 | 60 | |
| 11 | 2021 | 59 | |
| 12 | 2014 | 58 | |
| 13 | Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers Hit paper breakdown → | 2025 | 44 |
| 14 | 2018 | 43 | |
| 15 | 2022 | 42 | |
| 16 | 2019 | 38 | |
| 17 | 2017 | 32 | |
| 18 | 2016 | 31 | |
| 19 | 2025 | 29 | |
| 20 | 2013 | 28 |
About Zhican Wang
Zhican Wang is a scholar working on Pathology and Forensic Medicine, Pharmacology, Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Molecular Biology, having authored 31 papers that have together received 1.7k indexed citations. Recurring topics across this work include Vitamin D Research Studies (13 papers), Pharmacogenetics and Drug Metabolism (5 papers), Pharmacological Effects and Toxicity Studies (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Hormonal Regulation and Hypertension (2 papers), Vitamin C and Antioxidants Research (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Advanced Neural Network Applications (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (566 citations), Pharmacology (100 citations), Nutrition and Dietetics (168 citations), Nephrology (73 citations) and Oncology (243 citations). Zhican Wang has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Kenneth E. Thummel, Erin G. Schuetz, Yvonne S. Lin, Yang Xu, Connie L. Davis, Danny D. Shen, Jonathan Himmelfarb, Xi Zheng, Ian H. de Boer and Brian D. Chapron. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Medicinal Chemistry, Cancer Discovery, Science and Analytical and Bioanalytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.